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Orthosiphon stamineus (OS), locally known in Malaysia as ‘Misai Kucing’, is a 
herbaceous shrub belonging to the family Lamiaceae. Dried leaves of OS is gaining 
wide acceptance and marketed in the form of herbal tea, known as Java tea, owing to 
its traditional and scientific claims on various health benefits. OS has been a well-
known renoprotective agent primarily due to its diuretic potential. This research 
investigated the effects of commonly employed drying methods of OS leaves on their 
chemical constituent profile, and in vivo biological properties of the protective role in 
cisplatin induced nephrotoxicity using rats, through Nuclear Magnetic Resonance 
(NMR) metabolomics approach. The NMR spectra of rat urine and the OS leaf extracts 
were analysed and correlated using multivariate data analysis techniques employing 
metabolomics platform.  
 
The 1H NMR metabolite profiling of aqueous extract of OS leaves resulted in the 
identification of 31 metabolites. The presence of biologically active secondary 
metabolites including phenylpropanoids such as caffeic acid, protocatechuic acid, 
chlorogenic acid, flavonoids such as luteolin and apigenin, gallic acid and orthosiphol 
derivatives were confirmed by J resolved NMR technique. The HPLC - MS/MS 
analysis further confirmed the presence of these secondary metabolites. Metabolite 
fingerprinting in combination with multivariate analysis has successfully 
differentiated the three differently dried (Freeze, microwave and shade) OS leaves and 
established that the levels of 15 metabolites were varied significantly between the 
samples. The shade drying method retained maximum secondary metabolites followed 
by the microwave, while freeze drying retained the least. Assessment of the main 
beneficial properties, such as antioxidant, total phenolic and flavonoid contents of any 
tea preparation, confirmed that all the differently dried Java tea leaves gave good 
antioxidant activity, with the shade dried leaves recorded the highest level with an 
IC50 of 48.09 μg/mL. The chemical constituents correlated to the high antioxidant 
activity of the shade dried leaves were extracted from a Partial Least Square regression 
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(PLS) model. In addition, the toxicity profile of the microwave dried OS leaves was 
investigated through acute oral toxicity test in Sprague Dawley (SD) rats of both sexes, 
whereby, the no-observed-adverse-effect level (NOAEL) of aqueous, 50% ethanolic 
and ethanolic extracts of the microwave dried OS was determined as 5000 mg/kg body 
weight/day. Thus, it is presumed that the microwave dried leaves are safe to be used 
as an oral health supplement. 
 
Cisplatin is an anticancer drug, which induces nephrotoxicity in a long term use. 
Metabolomic analysis of the rats’ urine revealed the involvement of a total of 17 
biochemical markers from TCA cycle, carbohydrate, amino acid, and polyamine 
metabolic pathways in cisplatin nephrotoxicity. To the best of knowledge, 6 of the 17 
involved metabolites are newly established in this study. In order to evaluate the 
protective efficacy of OS in cisplatin nephrotoxicity, shade and microwave dried OS 
extracts were administered at doses of 100, 200 and 400 mg/kg body weight to rats.  
The results suggested the dose independency of the extracts. Treatment with 50% 
aqueous ethanolic extract of shade dried OS leaves (OSFS) exhibited moderate 
ameliorative effect observed through a statistically significant reduction in the levels 
of 8 biomarkers. It was also revealed that the aqueous extract of the shade dried leaves 
(OSAS) exhibited slightly deteriorative activity via disturbance in the energy 
metabolism and gut microflora. The higher concentration of the secondary metabolites 
such as caffeic acid, chlorogenic acid, protocatechuic acid and orthosiphol in OSFS 
could be correlated to the ameliorative activity as revealed from a Principal 
Component Analysis (PCA) between OSAS and OSFS. A prediction model on 
nephroprotective effect of OS was constructed through PLS regression analysis.  
 
Thus, the impact of different drying techniques on chemical constituents of OS leaves 
was established. The metabolomics approach has proved to be successful in shedding 
light to the even minute variations in the biological profiles of the low intensity 
metabolites involved in the renal toxicity caused by cisplatin. A global comprehensive 
view of the OS effect in cisplatin toxicity was successfully profiled and correlated. 
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Orthosiphon stamineus (OS), dikenali di Malaysia sebagai 'Misai Kucing'. Ia 
merupakan sejenis pokok herba renek dalam keluarga Lamiaceae. Daun OS yang telah 
dikeringkan semakin diterima ramai lalu dipasarkan dalam bentuk teh herba, yang 
dikenali sebagai teh jawa. Ini terjadi atas kepelbagaian manfaat kesihatan yang diuar-
uarkan melalui pendekatan tradisional dan saintifik. OS telah dikenali sebagai ejen 
perlindungan buah pinggang yang terkenal kerana potensi diuretiknya. Kajian 
mengenai kesan kaedah pengeringan yang telah biasa diamalkan turut dilakukan pada 
daun OS bagi menentukan profil konstituen kimianya serta kajian biologi turut 
dilakukan secara in vivo bagi memastikan peranan perlindungannya pada tikus aruhan 
cisplatin yang mengakibatkan kesan nefrotoksik. Ia dilakukan melalui pendekatan 
metabolomik Nuklear Magnetik Resonan (NMR). Spektrum NMR daripada sampel 
air kencing tikus dan estrak daun OS dianalisis dengan mengaitkan platform 
metabolomik menggunakan teknik analisis data multivariat. 
 
Metabolit profil pada 1H NMR ekstrak air daun OS telah mengenalpasti 31 jenis 
metabolit. Kehadiran metabolit biologi sekunder yang aktif termasuk phenyl-
propanoids seperti asid caffeic, asid protocatechuic, asid chlorogenic, flavonoid 
seperti luteolin dan apigenin, asid Gallic dan derivatif orthosiphol telah disahkan 
melalui teknik “J resolve” NMR. Analisis lanjut HPLC - MS / MS mengesahkan 
kehadiran metabolit sekunder ini. Teknik pengkelasan metabolit ditambah dengan 
analisa multivariat telah berjaya membezakan tiga kaedah pengeringan (sejuk beku, 
ketuhar gelombang mikro dan bawah teduhan) daun OS dan telah membuktikan 
bahawa 15 metabolit telah mengalami perbezaan ketara antara sampel. Kaedah 
pengeringan dibawah teduhan berjaya mengekalkan kehadiran metabolit sekunder 
yang paling tinggi diikuti oleh pengeringan gelombang mikro, serta penyejuk bekuan 
menunjukkan nilai yang paling rendah. Penilaian terhadap manfaat utama seperti 
antioksida mendapati, jumlah fenolik dan kandungan flavonoid sesuatu penyediaan 
teh mengesahkan bahawa kesemua daun teh jawa yang berbeza kaedah 
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pengeringannya memberikan aktiviti antioksidan yang baik di mana daun yang 
dikeringkan dibawah teduhan telah merakamkan nilai IC50 yang paling tinggi pada 
48.09 μg / mL. Selanjutnya analisa separa persegi (PLS) telah digunakan untuk 
mengenalpasti konstituen kimia yang bertanggungjawab terhadap aktiviti antioksida 
yang tinggi dalam daun OS yang dikeringkan di bawah teduhan ini. Di samping itu, 
profil toksik daun OS yang dikeringkan dengan menggunakan gelombang mikro telah 
dikaji dengan menjalankan ujian oral toksiti pada kedua-dua jantina tikus Sprague 
Dawley (SD). Keputusan menunjukkan tiada pemerhatian-taraf-kesan-buruk 
(NOAEL) bagi ekstrak air, 50% etanol dan etanol pada dos 5000 mg/kg berat 
badan/hari. Oleh itu, daun OS yang telah dikeringkan menggunakan gelombang mikro 
dianggap selamat untuk digunakan sebagai makanan tambahan kesihatan melalui oral. 
 
Cisplatin adalah ubat anti-kanser yang boleh menyebabkan implikasi nefrotoksik jika 
digunakan dalam jangka masa panjang. Analisa metabolomik ke atas air kencing tikus 
mendedahkan sebanyak 17 penanda biokimia daripada kitaran TCA, karbohidrat, asid 
amino, dan laluan metabolik poliamina dalam aktiviti nefrotoksik yang disebabkan 
oleh cisplatin. Enam, daripada 17 metabolit merupakan metabolit terbaru yang telah 
dibuktikan dalam kajian ini. Untuk menilai keberkesanan perlindungan OS dalam 
menangani kesan nefrotoksik ini, daun OS yang diekstrak melalui pengeringan di 
bawah teduhan dan ketuhar gelombang mikro telah digunakan dan diberi pada 
beberapa dos rawatan iaitu 100, 200 dan 400 mg / kg berat badan tikus. Hasil kajian 
mendapati keberkesanan ekstak tidak bergantung kepada dos rawatan yang diberikan. 
Sementara itu, awatan dengan 50% ekstrak ethanol daripada daun OS yang 
dikeringkan di bawah teduhan (OSFS) menunjukkan kesan rawatan yang sederhana. 
Ini disebabkan oleh pemerhatian terhadap kadar penurunan yang signifikan pada 8 
penandabio. Ia juga mendedahkan bahawa ekstrak air daripada daun OS yang 
dikeringkan di bawah teduhan (OSAS) hanya mempunyai sedikit penurunan nilai 
aktiviti melalui gangguan dalam metabolisme tenaga dan usus mikroflora. Metabolit 
sekunder yang lebih tinggi kepekatannya seperti asid caffeic, asid chlorogenic, asid 
protocatechuic dan orthosiphol dalam OSFS boleh dikaitkan dengan aktiviti membaik 
pulih seperti yang dinyatakan daripada Analisia Komponen Utama (PCA) antara 
OSAS dan OSFS. Satu model ramalan mengenai kesan nefroprotektif OS telah dibina 
melalui analisis regresi PLS. 
 
Oleh itu, kajian ini telah membuktikan bahawa teknik pengeringan yang berbeza akan 
memberi kesan kepada konstituen kimia dalam daun OS. Pendekatan metabolomik 
juga telah berjaya memberi penjelasan terhadap perubahan kecil dalam profil biologi 
metabolit yang terlibat dalam masalah toksik buah pinggang yang disebabkan oleh 
cisplatin. Rumusannya, liputan yang menyeluruh terhadap kesan toksik cisplatin telah 
berjaya diprofilkan dan dihubungkaitkan.  
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CHAPTER 1 
INTRODUCTION 
1.1 Research background 
Historically, plants have been the forerunners in the prevention and cure against a wide 
spectrum of diseases. Apart from their use in traditional system treatment, the 
abundant store of unique and diverse chemical compounds present in plants has served 
as a prominent source of lead molecules in the modern drug discovery process. This 
is evident from the fact that natural products (NP) and their derived compounds 
constitute a nearly 50% share of total new chemical entities approved in the span of 
the past 33 years, until December 2014 (Newman and Cragg, 2012; Newman and 
Cragg, 2016).  
However, the progress made in drug discovery in terms of the number of novel drugs 
based on NP is not in proportion with the magnitude of ethno-pharmacological claims 
on various plants. The commonly adopted approaches in NP research such as bioassay 
guided isolation of active principles and high throughput screening often failed to elicit 
the optimum activity. This is primarily due to the fact that the bioactivity of a plant 
often resulted from a cumulative interaction of a large number of phytoconstituents, 
which deprives the isolated compound from exhibiting the activity as how a complex 
matrix of crude extract does (Cordell and Colvard, 2012; Yuliana et al., 2013) .  
Recent developments in the field of systems biology such as metabolomics allow the 
evaluation of the biological activity of unfractionated complex extracts using proper 
bioassays (Robinette et al., 2011). Here, a broad range of analytical techniques such 
as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS) and/or 
chromatography characterises the complex diverse metabolite classes present in the 
crude extract and an overall picture of metabolites correlating to the bioactivity could 
be derived using proper data mining methods. Thus, this holistic approach facilitates 
the identification of multiple active compounds from a single extract and their 
interaction either synergistically or antagonistically in in vivo systems.  
Metabolomic fingerprinting has been applied to novel research areas such as 
pharmacological properties of medicinal plants, drug discovery via bioprospecting and 
quality control of herbal drugs. High-resolution NMR spectroscopy is a simple, 
powerful and fastest approach and has been used in the NP research to identify and 
correlate both primary and secondary plant metabolites with the elucidated bioactivity. 
The applications of NMR in metabolic profiling of plant extracts have been well 
reviewed in several recent articles (Kim et al., 2011; Schripsema, 2010).  
Orthosiphon stamineus (OS) is a herbal remedy used traditionally in the cure of 
various system disorders, primarily that of kidney. It is locally known as Misai Kucing 
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in Malaysia. An aqueous infusion of dried leaves of OS, known as Java tea, is widely 
consumed by the people in South - East Asia (SEA) and Europe as a health adjuvant 
and general tonic (Ameer et al., 2012; Yuliana et al., 2009). The standardization of 
herbal products is of paramount importance in order to ensure consistent biological 
effects. So far the standardisation of OS was based on the quantification of certain 
marker compounds such as rosmarinic acid or sinensetin, and the practice was to 
generalize the observed biological activity to the variations of these selected markers. 
However, the metabolomic approach offers a platform to realistically correlate the 
responsible metabolites to the activity, and enables simultaneous standardization of 
several compounds present in the extract with minimal time and effort.  
 
 
Variations in the metabolic profiles of NP might be due to multitude of factors 
including differences in species, pre- and post-harvesting methods, adulteration, and 
extraction among many others (Van der Kooy et al., 2009; Wang et al., 2009). The 
subsequent effects on bioactivity profile warrant proper monitoring of these 
metabolite changes in order to ensure their safe and effective usage. Drying technique 
deserves special attention as one of the most important variables in the preparation of 
Java tea (OS) leaves. A metabolomic analysis on the differently dried (shade, 
microwave and freeze) Java tea leaves thus would be helpful in fingerprinting the 
metabolites, which serves as the basis for standardisation and quality control tools. 
 
 
The metabolomics platform has proved its usefulness in the field of toxicology as it 
derives a comprehensive picture of the effect of toxin in the body by the determination 
of global metabolome levels and their interrelations (Ramirez et al., 2013). OS has 
been known particularly for the beneficial effects on renal system owing to its diuretic 
and free radical scavenging activities (Arafat et al., 2008; Olah et al., 2003). However, 
to the best of our knowledge, the potential of OS in the protection of kidney from 
toxins, which is one of the most important sites of toxicity, has not yet been studied. 
A systematic exploration using metabolomics allows the simultaneous understanding 
of the complex mode of action of the toxin as well as the potential intervention of the 
OS. The toxico-metabolomics approach thus helps in understanding the mechanisms 
of toxicity, identify the biomarkers, and predict the bioactivity of the extract, thus, 
results in improvement of safety, to the shortening of the lead identification and a cost 
reduction (Robertson et al., 2011; Ulrich-Merzenich et al., 2009).  
 
 
A holistic evaluation of long term perspective rational evidence-based herbal 
treatment could lead to the discovery and development of effective phytomedical 
intervention, taking into account the interaction of multiconstituents in synergism or 
antagonism, thus ensuring better safety and efficacy of the usage of herbs used in 
traditional system treatment.  
 
 
In this research, it is hypothesized that different drying methods employed in the 
production of OS leaves affect the chemical profile and biological properties of OS. 
Identification of a proper drying method, which retains maximum beneficial chemical 
constituents, and safe, as well as efficient pharmacological activity is important to be 
ensured before its usage. 
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1.2 Aims and objectives 
 
The work presented in this thesis aimed to investigate the effects of the drying methods 
exerted on the chemical and biological properties of OS leaves using NMR 
metabolomics approach. The metabolomics tool was employed to detect and 
discriminate the modulatory effects of OS on cisplatin nephrotoxicity. The general 
objective of this research was to evaluate the quality, safety, efficacy and consistency 
(QSEC) parameters of OS leaves with regard to different drying techniques employed.  
 
 
These were achieved through the following set of specific objectives: 
 
• To establish the metabolic fingerprint of shade, microwave and freeze dried 
OS leaf extracts, and to correlate their antioxidant activity with the overall 
bioactive compounds.  
• To determine primary toxicity profile of microwave dried OS leaves.  
• To identify the biomarkers and underlying metabolic pathways involved in 
cisplatin nephrotoxicity. 
• To evaluate the modulatory effect of various OS extracts in cisplatin-induced 
nephrotoxic biomarkers and to develop a validated regression model, 
correlating the phytoconstituents to nephroprotective activity. 
 
 
1.3 Outline of thesis 
 
This thesis is presented in seven chapters. The general introduction is described in 
Chapter 1. Chapter 2 focusses on the comprehensive review of the literatures related 
to this research. Relevant literatures on pharmacological and phytochemical studies 
on OS, metabolomics and cisplatin nephrotoxicity are reviewed. Chapter 3 discusses 
the application of nuclear magnetic resonance (NMR) spectroscopy and chemometric 
methods in achieving the metabolic fingerprint of shade, microwave and freeze dried 
leaves. The correlation of antioxidant activity of the OS leaf to its phytoconstituents 
was established using Partial Least Square (PLS) regression analysis. Chapter 4 
emphasizes on the preliminary phytochemical and toxicological studies on microwave 
dried OS leaves. A comparative evaluation of the microwave and shade dried OS 
leaves chemical constituent profile using liquid chromatography-mass spectrometry 
(LC-MS/MS) analysis and an acute oral toxicity test to assess the safety of microwave 
dried OS leaves are described here. Chapter 5 deals with the NMR spectroscopic 
profiling of the metabolites in cisplatin nephrotoxic and normal rats. The chemometric 
data analysis tools were used to identify the biomarkers and the underlying metabolic 
pathways involved in cisplatin nephrotoxicity. Chapter 6 discusses the NMR 
metabolomic analysis of rat urine in order to understand the metabolic perturbations 
induced by the OS intervention in cisplatin nephrotoxic biomarkers. A correlation 
model comprising of the nephroprotective activity with the phytoconstituents of OS 
was established using PLS. Finally, the overall conclusions are summarised in chapter 
7, along with the future perspectives of the results obtained in this thesis.  
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